Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lim

Showing results (291-300 of 328) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2007
A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafnessR Ficarella, F Di Leva, M Bortolozzi, et al.
ACS Chemical Neuroscience|May 15, 2025
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D<sub>2</sub> ReceptorHerman D Lim, Damian Bartuzi, Alastair C Keen, et al.
European Urology Oncology|July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 PatientsJustin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesW P Yong, B C Goh, R A Soo, et al.
Molecular Pharmacology|September 28, 2011
Identification of a novel allosteric binding site in the CXCR2 chemokine receptorPetra de Kruijf, Herman D Lim, Luc Roumen, et al.
Urologic Oncology|July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinomaDaniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
Nurse Education in Practice|March 19, 2026
Reframing intraoperative learning in undergraduate nursing education: Moving from exposure to structured capability developmentZenas B Paloma, Hazel P Agbayani, James D Lim, et al.
European Journal of Pharmacology|April 5, 2011
N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 releaseSaskia A Overbeek, Paul A J Henricks, Anja I Srienc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.
European Urology Oncology|July 6, 2019
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II TrialNizar M Tannir, Pavlos Msaouel, Jeremy A Ross, et al.
Pageof 33

Showing results (291-300 of 328) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2007
A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafnessR Ficarella, F Di Leva, M Bortolozzi, et al.
ACS Chemical Neuroscience|May 15, 2025
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D<sub>2</sub> ReceptorHerman D Lim, Damian Bartuzi, Alastair C Keen, et al.
European Urology Oncology|July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 PatientsJustin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesW P Yong, B C Goh, R A Soo, et al.
Molecular Pharmacology|September 28, 2011
Identification of a novel allosteric binding site in the CXCR2 chemokine receptorPetra de Kruijf, Herman D Lim, Luc Roumen, et al.
Urologic Oncology|July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinomaDaniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
Nurse Education in Practice|March 19, 2026
Reframing intraoperative learning in undergraduate nursing education: Moving from exposure to structured capability developmentZenas B Paloma, Hazel P Agbayani, James D Lim, et al.
European Journal of Pharmacology|April 5, 2011
N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 releaseSaskia A Overbeek, Paul A J Henricks, Anja I Srienc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.
European Urology Oncology|July 6, 2019
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II TrialNizar M Tannir, Pavlos Msaouel, Jeremy A Ross, et al.
Pageof 33